ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
18520.2 PFLS-LS
Project title
Evaluation of combining KISIMA vaccine technology platform with Immune Checkpoint Inhibitors for improved cancer immunotherapy treatment

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Doktor
Paul Walker
Université de Genève
Rue Gabrielle-Perret-Gentil 4
CH-1211 Genève
+41 22 372 9880
Paul.Walker@hcuge.ch

Implementation Partner

Doktor
Madiha Derouazi
Amal Therapeutics SA
Avenue de la Roseraie 64
CH-1205 Genève
+41 22 372 38 05
madiha.derouazi@amaltherapeutics.com